Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-α gene expression signature in SAMP1 mice
✍ Scribed by Constance Schmelzer; Hiroshi Kubo; Masayuki Mori; Jinko Sawashita; Mitsuaki Kitano; Kazunori Hosoe; Inka Boomgaarden; Frank Döring; Keiichi Higuchi
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 250 KB
- Volume
- 54
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
✦ Synopsis
Our present study reveals significant decelerating effects on senescence processes in middle-aged SAMP1 mice supplemented for 6 or 14 months with the reduced form (Q 10 H 2 , 500 mg/kg BW/ day) of coenzyme Q 10 (CoQ 10 ). To unravel molecular mechanisms of these CoQ 10 effects, a genome-wide transcript profiling in liver, heart, brain and kidney of SAMP1 mice supplemented with the reduced (Q 10 H 2 ) or oxidized form of CoQ 10 (Q 10 ) was performed. Liver seems to be the main target tissue of CoQ 10 intervention, followed by kidney, heart and brain. Stringent evaluation of the resulting data revealed that Q 10 H 2 has a stronger impact on gene expression than Q 10 , primarily due to differences in the bioavailability. Indeed, Q 10 H 2 supplementation was more effective than Q 10 to increase levels of CoQ 10 in the liver of SAMP1 mice. To identify functional and regulatory connections of the ''top 50'' (po0.05) Q 10 H 2 -sensitive transcripts in liver, text mining analysis was used. Hereby, we identified Q 10 H 2 -sensitive genes which are regulated by peroxisome proliferator-activated receptor-a and are primarily involved in cholesterol synthesis (e.g. HMGCS1, HMGCL and HMGCR), fat assimilation (FABP5), lipoprotein metabolism (PLTP) and inflammation (STAT-1). These data may explain, at least in part, the decelerating effects on degenerative processes observed in Q 10 H 2 -supplemented SAMP1 mice.